DE3885752D1 - Methode und verbindungen zur herstellung von acsf und acsf-antagonisten. - Google Patents

Methode und verbindungen zur herstellung von acsf und acsf-antagonisten.

Info

Publication number
DE3885752D1
DE3885752D1 DE88905121T DE3885752T DE3885752D1 DE 3885752 D1 DE3885752 D1 DE 3885752D1 DE 88905121 T DE88905121 T DE 88905121T DE 3885752 T DE3885752 T DE 3885752T DE 3885752 D1 DE3885752 D1 DE 3885752D1
Authority
DE
Germany
Prior art keywords
acsf
compounds
producing
antagonists
acsf antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE88905121T
Other languages
English (en)
Other versions
DE3885752T2 (de
Inventor
Thomas Martin
Larry Suva
William Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Genentech Inc
Original Assignee
University of Melbourne
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Melbourne, Genentech Inc filed Critical University of Melbourne
Application granted granted Critical
Publication of DE3885752D1 publication Critical patent/DE3885752D1/de
Publication of DE3885752T2 publication Critical patent/DE3885752T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/66—Thymopoietins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
DE3885752T 1987-05-20 1988-05-19 Methode und verbindungen zur herstellung von acsf und acsf-antagonisten. Expired - Lifetime DE3885752T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5263787A 1987-05-20 1987-05-20
PCT/US1988/001652 WO1988009376A1 (en) 1987-05-20 1988-05-19 Method and compositions for making acsf and acsf antagonists

Publications (2)

Publication Number Publication Date
DE3885752D1 true DE3885752D1 (de) 1993-12-23
DE3885752T2 DE3885752T2 (de) 1994-06-16

Family

ID=21978909

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3885752T Expired - Lifetime DE3885752T2 (de) 1987-05-20 1988-05-19 Methode und verbindungen zur herstellung von acsf und acsf-antagonisten.

Country Status (7)

Country Link
US (2) US5656455A (de)
EP (1) EP0362272B1 (de)
JP (3) JP2795657B2 (de)
AU (1) AU606972B2 (de)
CA (1) CA1341048C (de)
DE (1) DE3885752T2 (de)
WO (1) WO1988009376A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096933C (en) * 1990-12-13 2003-05-13 Bruce E. Kemp Compounds and compositions which inhibit bone resorption
JP2715187B2 (ja) * 1991-01-30 1998-02-18 株式会社第一ラジオアイソトープ研究所 ＰＴＨｒＰの免疫学的測定方法
JP3781771B2 (ja) * 1993-06-29 2006-05-31 生化学工業株式会社 新規ポリペプチド及びそれをコードするｄｎａ
EP0649910A1 (de) * 1993-10-22 1995-04-26 Sumitomo Electric Industries, Limited DNA-Probe zur Detektion allergischer Krankheiten, Detektionsprozess für allergische Krankheiten hervorrüfendes Gen mittels einer solchen Probe
ATE363289T1 (de) * 1995-02-20 2007-06-15 Yukio Kato Heilmittel für arthrosis deformans und entzündliche gelenkerkrankungen
US7820393B2 (en) * 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en) 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
WO1988000596A1 (en) * 1986-07-18 1988-01-28 The University Of Melbourne A PROTEIN ACTIVE IN HUMORAL HYPERCALCEMIA OF MALIGNANCY-PTHrP
US4968669A (en) * 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
US5114843A (en) * 1988-05-09 1992-05-19 Merck & Co., Inc. Humoral hypercalcemic factor antagonists
US5149779A (en) * 1990-07-26 1992-09-22 Merck & Co., Inc. Humoral hypercalcemic factor antagonists

Also Published As

Publication number Publication date
DE3885752T2 (de) 1994-06-16
CA1341048C (en) 2000-07-11
US5763195A (en) 1998-06-09
JP2795657B2 (ja) 1998-09-10
AU606972B2 (en) 1991-02-21
JPH02504579A (ja) 1990-12-27
AU1939488A (en) 1988-12-21
US5656455A (en) 1997-08-12
EP0362272B1 (de) 1993-11-18
JP3406294B2 (ja) 2003-05-12
WO1988009376A1 (en) 1988-12-01
EP0362272A1 (de) 1990-04-11
JP2001206898A (ja) 2001-07-31
JPH10338643A (ja) 1998-12-22

Similar Documents

Publication Publication Date Title
DE3887625D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
DE3888885D1 (de) Halbleiteranordnung und verfahren zur herstellung.
DE3774592D1 (de) Methode zur herstellung von schuppenaehnlichem gut.
DE3688057D1 (de) Halbleitervorrichtung und methode zur herstellung.
DE68923464D1 (de) Verfahren zur Herstellung von Erythritol.
DE3850802D1 (de) Verbindungen zur Bestimmung von Kationen.
DE3767680D1 (de) Methode zur herstellung von adiponitril.
DE3870633D1 (de) Verfahren zur herstellung von butyrolactonen und von butandiolen.
DE3669507D1 (de) 1-benzyl-2-(n-substituierte)-carbamoyltetrahydroisochinoline und methode zur ihrer herstellung.
DE68917457D1 (de) Deodorant und verfahren zur herstellung.
DE68913447D1 (de) Verfahren zur Herstellung von Halofluorbenzolen.
DE3787543D1 (de) Verfahren zur herstellung von 6,13-dihydrochinacridonen und chinacridonen.
DE3684922D1 (de) Verfahren zur herstellung von 2-phenylbenzotriazolen und 2-phenylbenzotriazol-n-oxyden.
DE3888443D1 (de) Verfahren zur Herstellung von Dihydrochinacridonen, Chinacridonen und Chinacridonchinonen.
DE3885752D1 (de) Methode und verbindungen zur herstellung von acsf und acsf-antagonisten.
DE3861189D1 (de) Verfahren zur herstellung von polysilazanen.
DE68922275D1 (de) Verfahren zur Herstellung von Monochloroacetaldehyde-Trimer.
DE3885262D1 (de) Verfahren zur Herstellung von 2-Chlor-5-methyl-pyridin.
DE3671246D1 (de) Verfahren zur herstellung von 4-androsten-3,17-dion und 1,4-androstadien-3,17-dion.
DE3751186D1 (de) Verfahren zur Herstellung von modifizierten Polycycloolefinen.
DE3786870D1 (de) Methode zur herstellung von proteinen.
DE3765855D1 (de) Dimethylphenylsilylmethylpolysilan und verfahren zur herstellung desselben.
DE58905592D1 (de) Verfahren zur Herstellung von N-Hydroxypyrazolen.
DE58907097D1 (de) Verfahren zur Herstellung von 4-Chlorpyrazolen.
DE58905664D1 (de) Verfahren zur Herstellung von N-Hydroxypyrazolen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition